Phosphonic Acid

Phosphonic Acid

SCHEMBL891504

O=[PH]([O-])O.O=[PH]([O-])O.[Na+].[Na+]

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Phosphonic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA4 known ✓ P22748 1/20 0.31
FAHD1 Q6P587 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117137833-A Composition rich in hydroxypropyl tetrahydropyran triol and preparation method thereof 上海科黛生物科技有限公司 2023-12-01 CN claimed
EP-1969020-B1 A MANUFACTURING METHOD OF CO-POLYESTER RESINS FOR CLEAR MONO-LAYER CONTAINERS WITH IMPROVED GAS BARRIER CHARACTERISTICS DAK AMERICAS LLC (US) 2024-09-18 EP disclosed
EP-3153310-B1 A PROCESS FOR MANUFACTURING CO-POLYESTER BARRIER RESINS WITHOUT SOLID-STATE POLYMERIZATION, CO-POLYESTER RESINS MADE BY THE PROCESS, AND CLEAR MONO-LAYER CONTAINERS MADE OF THE CO-POLYESTER RESINS DAK AMERICAS LLC (US) 2024-01-03 EP disclosed
CN-117137833-A Composition rich in hydroxypropyl tetrahydropyran triol and preparation method thereof 上海科黛生物科技有限公司 2023-12-01 CN disclosed
WO-2022069091-A1 REDUCING STAIN AGENT ADLER-Werk Lackfabrik Johann Berghofer GmbH & Co. KG (AT) 2022-04-07 WO disclosed
CN-106939125-B Flame-resistant semi-aromatic polyamide moulding compositions EMS 专利股份公司 2020-12-29 CN disclosed
EP-3153310-A1 A PROCESS FOR MANUFACTURING CO-POLYESTER BARRIER RESINS WITHOUT SOLID-STATE POLYMERIZATION, CO-POLYESTER RESINS MADE BY THE PROCESS, AND CLEAR MONO-LAYER CONTAINERS MADE OF THE CO-POLYESTER RESINS Dak Americas LLC (US) 2017-04-12 EP disclosed
US-9394424-B2 Flame-protected, partially aromatic polyamide molding compounds EMS-PATENT AG (CH) 2016-07-19 US disclosed
US-20150316847-A1 HOMOADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME AND PHOTOSENSITIVE MATERIALS FOR PHOTORESIST OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) 2015-11-05 US disclosed
US-20130022914-A1 HOMOADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME AND PHOTOSENSITIVE MATERIALS FOR PHOTORESIST IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20120083558-A1 FLAME-PROTECTED, PARTIALLY AROMATIC POLYAMIDE MOLDING COMPOUNDS EMS-PATENT AG (CH) 2012-04-05 US disclosed
EP-1969020-A2 A MANUFACTURING METHOD OF CO-POLYESTER RESINS FOR CLEAR MONO-LAYER CONTAINERS WITH IMPROVED GAS BARRIER CHARACTERISTICS Dak Americas, Llc (US) 2008-09-17 EP disclosed
EP-1957260-A2 A PROCESS FOR MANUFACTURING CO-POLYESTER BARRIER RESINS WITHOUT SOLID-STATE POLYMERIZATION, CO-POLYESTER RESINS MADE BY THE PROCESS, AND CLEAR MONO-LAYER CONTAINERS MADE OF THE CO-POLYESTER RESINS Dak Americas, Llc (US) 2008-08-20 EP disclosed
US-7358324-B2 Manufacturing method of co-polyester resins for clear mono-layer containers with improved gas barrier characteristics DAK AMERICAS LLC (US) 2008-04-15 US disclosed
WO-2007067518-A2 A PROCESS FOR MANUFACTURING CO-POLYESTER BARRIER RESINS WITHOUT SOLID-STATE POLYMERIZATION DAK AMERICAS LLC (US) 2007-06-14 WO disclosed
WO-2007067421-A2 A MANUFACTURING METHOD OF CO-POLYESTER RESINS FOR CLEAR MONO-LAYER CONTAINERS WITH IMPROVED GAS BARRIER CHARACTERISTICS DAK AMERICAS LLC (US) 2007-06-14 WO disclosed
US-20070129501-A1 Manufacturing method of co-polyester resins for clear mono-layer containers with improved gas barrier characteristics DAK AMERICAS LLC (US) 2007-06-07 US disclosed
US-20070128389-A1 Process for manufacturing co-polyester barrier resins without solid-state polymerization, co-polyester resins made by the process, and clear mono-layer containers made of the co-polyester resins DAK AMERICAS LLC (US) 2007-06-07 US disclosed
US-4048156-A PLANT GROWTH REGULATORS E. I DU PONT DE NEMOURS AND COMPANY (US) 1977-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130022914-A1 HOMOADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME AND PHOTOSENSITIVE MATERIALS FOR PHOTORESIST CRY1, HPD, CRY2 CA4 1519/4885FAHD1 4102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.